Non-invasive cardiology, in contrast, utilizes imaging techniques and diagnostic tests that do not require the insertion of instruments into the body. These methods include electrocardiography (ECG or EKG), echocardiography, nuclear cardiology, and cardiac magnetic resonance imaging (MRI). Non-invasive approaches are often employed for initial screenings, routine assessments, and ongoing monitoring of cardiovascular health. ECG, for example, records the heart's electrical activity, while echocardiography uses ultrasound to visualize the heart's structure and function. Non-invasive cardiology is valuable in detecting various cardiovascular conditions, such as arrhythmias, heart valve disorders, and congenital heart defects. While these methods are generally lower in risk and more accessible, they may have limitations in terms of the level of detail provided compared to invasive procedures. Non-invasive cardiology plays a crucial role in preventive care, early diagnosis, and long-term management of cardiovascular diseases, contributing to comprehensive and patient-centered cardiological practice.
Title : Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic
Agustin Joison, Cordoba Catholic University, Argentina
Title : Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing Cardiac Hospital Networks
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibody-proteases as unique biomarkers, potential targets and translational tools of the next step generation to be used in personalized and precision cardiology practice
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Investigation of bergapten’s pharmacological activity against doxorubicin induced cardiotoxicity: supporting evidence from cellular and animal models
Bijoy Krishna Banik, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, India